Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials. [electronic resource]
Producer: 20130402Description: 705-12 p. digitalISSN:- 1941-7632
- Aged
- Chi-Square Distribution
- Coronary Thrombosis -- blood
- Drug Therapy, Combination
- Female
- Fibrinolytic Agents -- adverse effects
- Hemorrhage -- chemically induced
- Heparin -- adverse effects
- Hirudins -- adverse effects
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Myocardial Infarction -- blood
- Odds Ratio
- Peptide Fragments -- adverse effects
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Recombinant Proteins -- adverse effects
- Recurrence
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.